US Global Investors Funds’s AbbVie ABBV Stock Holding History

US Global Investors Funds’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$290K	Buy	+5,500	New	+$270K	0.05%	200

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

US Global Investors Funds's ABBV Position: Q4 2013 in Review

US Global Investors Funds opened a new position in AbbVie (ABBV) in Q4 2013: 5,500 shares worth $290K. The stake represents 0.05% of the portfolio and ranks #200 among its holdings.

1,435 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

US Global Investors Funds held 5,500 shares of AbbVie worth $290K as of Q4 2013.
AbbVie was a new US Global Investors Funds position in Q4 2013.
AbbVie made up 0.05% of US Global Investors Funds's portfolio in Q4 2013, its #200 holding.
1,435 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.